Completed PHASE4 INTERVENTIONAL 2-arm NCT00700375

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection in Patients Undergoing an Emergent Coronary Procedure

Sponsor: Osaka General Medical Center

Conditions Emergent Coronary Procedure

Interventions Sodium Chloride Sodium bicarbonate

Updated 9 times since 2017 Last updated: Jul 12, 2010 Started: Jul 31, 2008 Primary completion: Mar 31, 2010 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Emergent Coronary Procedure, this trial is completed. The trial is conducted by Osaka General Medical Center and has accumulated 9 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Dec 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Osaka General Medical Center

Data source: Osaka General Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Osaka, Japan